Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells

Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder. Current targeted therapies designed to inhibit the tyrosine kinase activity of the BCR-ABL oncoprotein have made a significant breakthrough in the treatment of CML patients. However, CML remains a chronic disease that a patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamad, Ahmad, Sahli, Zeyad, El Sabban, Maya, Mouteirik, Maha, Nasr, Rihab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725740/
https://www.ncbi.nlm.nih.gov/pubmed/23935640
http://dx.doi.org/10.1155/2013/724360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725740/
https://www.ncbi.nlm.nih.gov/pubmed/23935640
http://dx.doi.org/10.1155/2013/724360

Ejemplares similares